Bayesian Stacking of Quantitative Adverse Outcome Pathways Isolates Primary Drivers of Liver Steatosis
Anna Melina Steinbach, Philip Marx‐Stoelting, Christian Tobias Willenbockel
This paper develops a Bayesian framework to integrate multiple converging pathways in adverse outcome pathways, demonstrating improved predictive performance for liver steatosis.
bioRxiv · Oct 25, 2026 · PreprintPharmacology & Toxicology